6-Chloro-1,3-dihydroindol-2-one → 6-[8-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-2-ylamino]-1,3-dihydro-indol-2-one
Reaction equation
[CH3:1][N:2]1[CH:6]=[C:5]([C:7]2[C:8]3[N:9]([N:13]=[C:14]([NH2:16])[N:15]=3)[CH:10]=[CH:11][N:12]=2)[CH:4]=[N:3]1.Cl[C:18]1[CH:26]=[C:25]2[C:21]([CH2:22][C:23](=[O:27])[NH:24]2)=[CH:20][CH:19]=1>>[CH3:1][N:2]1[CH:6]=[C:5]([C:7]2[C:8]3[N:9]([N:13]=[C:14]([NH:16][C:18]4[CH:26]=[C:25]5[C:21]([CH2:22][C:23](=[O:27])[NH:24]5)=[CH:20][CH:19]=4)[N:15]=3)[CH:10]=[CH:11][N:12]=2)[CH:4]=[N:3]1Participants
3
Procedure
8-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-2-amine, synthesized as described earlier, is coupled with 6-chloro-oxindol according to general procedure 2.
Sources & evidence
- ORD record
- ord-95e9e90ed3784d53a5f9adb7bce6f6b3
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120804B2
Reaction notes
Loading…